ARAY
ARAY clinical trials: ACCURAY INC
Every trial on ClinicalTrials.gov where ACCURAY INC is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 13
- Trials linked
- 6
- As lead sponsor
- 7
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
ARAY on the catalyst calendar · ARAY registry changes
- Primary completion Apr 7, 2022ActualNo phase registeredNCT00643617CyberKnife Radiosurgery For Low & Intermediate Risk Prostate Cancer: Emulating HDR Brachytherapy DosimetryAccuray Incorporated · Prostate CancerCompletedARAYLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 27, 2021ActualNo phase registeredNCT00643994CyberKnife Radiosurgery for Organ-Confined Prostate Cancer: Homogenous Dose DistributionAccuray Incorporated · Prostate CancerCompletedARAYLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2021Sponsor estimatePhase 2NCT00643318CyberKnife Radiosurgical Treatment of Inoperable Early Stage Non-Small Cell Lung CancerAccuray Incorporated · Non-small Cell Lung CancerUnknown statusARAYLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 2013ActualNo phase registeredNCT00840749Randomized Study to Compare CyberKnife to Surgical Resection In Stage I Non-small Cell Lung CancerAccuray Incorporated · Non-small Cell Lung CancerTerminatedARAYLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 2013ActualPhase 2NCT01318447CyberKnife® for Hepatic Metastases From Colorectal CancerAccuray Incorporated · Colorectal Liver MetastasesTerminatedARAYLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 2014Sponsor estimatePhase 3NCT01318200Transarterial Chemoembolization (TACE) vs. CyberKnife for Recurrent Hepatocellular Carcinoma (HCC)Accuray Incorporated · Recurrent Hepatocellular CarcinomaWithdrawnARAYLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 2031Sponsor estimatePhase 1NCT07852247SBRT for Ultra-Central NonSmall Cell Lung CancerGeorgetown University · Nonsmall Cell Lung Cancer StageNot yet recruitingARAYCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 15, 2024ActualNo phase registeredNCT03377517Radiosurgical Hypophysectomy for Bone Metasteses PainSidney Kimmel Comprehensive Cancer Center at Johns Hopkins · Bone MetastasesTerminatedARAYCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 1, 2030Sponsor estimateNo phase registeredNCT07691255MELanoma Brain Metastasis Treated With CYberknifeEuropean Institute of Oncology · Melanoma (Skin Cancer)RecruitingARAYCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 25, 2021ActualPhase 2NCT02701088Study of SIB-IMRT in Combination With 5-FU and Mitomycin-C Among Patients With Locally Advanced Anal Canal Cancer: Efficacy, Safety and...Centre Francois Baclesse · Locally Advanced Anal Canal CancerCompletedARAYCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 2026Sponsor estimateNo phase registeredNCT06360653a SIngle Center Study of Post-operative STEReotactic RAdiotherapY for Endometrial CancerARNAS Civico Di Cristina Benfratelli Hospital · Endometrial CancerRecruitingARAYCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 27, 2021ActualPhase 1NCT02716948SRS and Nivolumab in Treating Patients With Newly Diagnosed Melanoma Metastases in the Brain or SpineSidney Kimmel Comprehensive Cancer Center at Johns Hopkins · Metastatic Malignant Neoplasm in the BrainCompletedARAYCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 2014Sponsor estimatePhase 3NCT01327521Transarterial Chemoembolization vs CyberKnife for Recurrent Hepatocellular CarcinomaAlbert Koong · Carcinoma, HepatocellularWithdrawnARAYCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 13 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner